| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
| mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
| mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.0098 |
0.9 |
| mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |